These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 21321478)

  • 1. Ivermectin, 'wonder drug' from Japan: the human use perspective.
    Crump A; Ōmura S
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(2):13-28. PubMed ID: 21321478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin: 25 years and still going strong.
    Omura S
    Int J Antimicrob Agents; 2008 Feb; 31(2):91-8. PubMed ID: 18037274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin: panacea for resource-poor communities?
    Omura S; Crump A
    Trends Parasitol; 2014 Sep; 30(9):445-55. PubMed ID: 25130507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin 20 years on: maturation of a wonder drug.
    Geary TG
    Trends Parasitol; 2005 Nov; 21(11):530-2. PubMed ID: 16126457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?
    Löscher W
    Epilepsia; 2023 Mar; 64(3):553-566. PubMed ID: 36645121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug".
    Sulik M; Antoszczak M; Huczyński A; Steverding D
    Eur J Med Chem; 2023 Dec; 261():115838. PubMed ID: 37793327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening the range of use cases for ivermectin - a review of the evidence.
    Kositz C; Bradley J; Hutchins H; Last A; D'Alessandro U; Marks M
    Trans R Soc Trop Med Hyg; 2022 Mar; 116(3):201-212. PubMed ID: 34323283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin: uses and impact 20 years on.
    Fox LM
    Curr Opin Infect Dis; 2006 Dec; 19(6):588-93. PubMed ID: 17075336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.
    Doyle SR; Bourguinat C; Nana-Djeunga HC; Kengne-Ouafo JA; Pion SDS; Bopda J; Kamgno J; Wanji S; Che H; Kuesel AC; Walker M; Basáñez MG; Boakye DA; Osei-Atweneboana MY; Boussinesq M; Prichard RK; Grant WN
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005816. PubMed ID: 28746337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents.
    Campbell WC
    Curr Pharm Biotechnol; 2012 May; 13(6):853-65. PubMed ID: 22039784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations.
    Crump A
    J Antibiot (Tokyo); 2017 May; 70(5):495-505. PubMed ID: 28196978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ivermectin use in tropical medicine].
    Dupouy-Camet J; Yera H; Tourte-Schaefer C
    Arch Pediatr; 2003 Dec; 10 Suppl 5():545s-549s. PubMed ID: 15022779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
    Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
    PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin, a potential anticancer drug derived from an antiparasitic drug.
    Tang M; Hu X; Wang Y; Yao X; Zhang W; Yu C; Cheng F; Li J; Fang Q
    Pharmacol Res; 2021 Jan; 163():105207. PubMed ID: 32971268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
    Lustigman S; McCarter JP
    PLoS Negl Trop Dis; 2007 Aug; 1(1):e76. PubMed ID: 17989789
    [No Abstract]   [Full Text] [Related]  

  • 16. The advent of ivermectin: people, partnerships, and principles.
    Crump A
    Trends Parasitol; 2014 Sep; 30(9):423-5. PubMed ID: 25168585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The life and times of ivermectin - a success story.
    Omura S; Crump A
    Nat Rev Microbiol; 2004 Dec; 2(12):984-9. PubMed ID: 15550944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparasitic antibiotics from Japan.
    Shiomi K
    Parasitol Int; 2021 Jun; 82():102298. PubMed ID: 33548522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from the History of Ivermectin and Other Antiparasitic Agents.
    Campbell WC
    Annu Rev Anim Biosci; 2016; 4():1-14. PubMed ID: 26515271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.